Newpage Solutions Achieves Net Zero Status — Pharma Get's a Sustainable Tech Partner for 2026

MIAMI - Nov. 7, 2025 - PRLog -- Newpage Solutions, a global technology partner to the life sciences and healthcare industries, today announced that it has officially achieved Net Zero emissions for Scope 1 and 2, marking a major milestone in sustainable digital transformation. This achievement positions Newpage as one of the few top technology partners that pharmaceutical, biotechnology, and medical device companies can confidently include in their sustainability and ESG supply chain audits.

In the words of Syed Arshad, CEO of Newpage Solutions,

"We don't just help life sciences companies innovate; we help them innovate responsibly. Our Net Zero status gives our clients the assurance that their digital transformation is aligned with their sustainability commitments."

Built, Not Bought: How Newpage Engineered Its Net Zero Transition

"Every decision — from how we code to how we collaborate — was redesigned to reduce our carbon footprint," said Kevin Sprague, CTO of Newpage Solutions.
"We call it 'Net Zero by Design.' Sustainability isn't an afterthought; it's part of the engineering DNA."

Key actions included:

• Eliminating office and commuting emissions through a fully remote work model.
• Using carbon-efficient cloud services and autoscaling architectures to prevent energy overuse.
• Adopting device lifecycle management and sustainable procurement policies.
• Conducting a full carbon audit across operations, verified by independent third-party assessors.

Why It Matters for Pharma and Biotech

Newpage's Net Zero achievement directly supports pharma clients in meeting sustainability objectives by providing:

• Net Zero technology solutions for pharma — helping reduce emissions linked to software delivery and IT infrastructure.
• Sustainable IT for life sciences — built on carbon-efficient, autoscaling cloud systems.
• Green digital transformation in pharmaceuticals — ensuring digital health and AI innovation align with ESG goals.
• Eco-friendly AI and automation for life sciences — delivering intelligent systems that optimize energy use and reduce waste.
• Decarbonization in pharma IT operations — measurable, traceable carbon reduction across digital ecosystems

By 2030, Newpage aims to achieve Net Zero across its entire value chain, guided by the Science Based Targets initiative (SBTi) framework.

Newpage's technology offerings—spanning AI and automation, CRM and Martech, cloud and integration, digital health platforms, and testing automation—are now powered by sustainable operations that align with the ESG priorities of modern life sciences organizations.

"Becoming Net Zero isn't the end of our journey," said Arshad.
"It's the foundation for everything we build next — technology that's good for people, and good for the planet."

🌐 Learn more: https://www.newpage.io
📩 Contact: info@newpage.io